Jump Financial’s Aerie Pharmaceuticals AERI Stock Holding History

Jump Financial’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-45,846	Closed	-$694K	–	2156
2022 Q3	$694K	Buy	+45,846	New	+$533K	0.03%	758
2022 Q2	–	Sell	-21,780	Closed	-$198K	–	2156
2022 Q1	$198K	Buy	+21,780	New	+$168K	0.01%	1311
2021 Q3	–	Sell	-19,958	Closed	-$320K	–	1639
2021 Q2	$320K	Buy	19,958 +4,642	+30%	+$79.6K	0.03%	647
2021 Q1	$273K	Buy	+15,316	New	+$265K	0.03%	643

Jump Financial's AERI Position: Q4 2022 in Review

Jump Financial sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 45,846 shares — an estimated $694K sold.

Jump Financial first reported a position in AERI in Q1 2021 and held it in 4 quarters. The position peaked at $694K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Jump Financial reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Jump Financial sold 45,846 Aerie Pharmaceuticals shares in Q4 2022, an estimated $694K.
Jump Financial first reported a position in Aerie Pharmaceuticals in Q1 2021 and held it in 4 quarters.
Jump Financial's Aerie Pharmaceuticals position peaked at $694K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Jump Financial's 13F filing for Q4 2022, filed 14 Feb 2023.